The Wellion SARS-CoV-2 PLUS ANTIGEN rapid test is used to detect a capsule protein of the virus (=antigen), and can thus make an acute infection at Covid-19 visible.
The test is carried out by taking a sample from the nasopharynx, and medical personnel evaluate the test in just 15 minutes.
The test is suitable for symptomatic and asymptomatic individuals and can also be performed on the move without the need for laboratory equipment. It is ideal for screening people who have been in contact with people infected with SARS-Cov-2 or people working in a high-risk environment.
The Wellion SARS-CoV2 PLUS ANTIGEN rapid test also detects mutations (e.g. South African, Brazilian, British and Indian mutation) of the SARS-CoV-2 virus.
3 types of sampling possible
- Nasal swab (anterior nasal)
- Nasopharyngeal swab
- Oropharyngeal swab
Sensitivity
- Sensitivity Nasal: 96,69%
- Sensitivity Oropharyngeal: 96,69%
- Sensitivity Nasopharyngeal: 96,33%
Specificity
- Specificity Nasal: 99,48%
- Specificity Oropharyngeal: 99,48%
- Specificity Nasopharyngeal: 99,67%
Clinical accuracy
- Clinical accuracy Nasal: 98,68%
- Clinical accuracy Oropharyngeal: 98,68%
- Clinical accuracy Nasopharyngeal: 98,78%
How to use:
Barcode: 9120105201537
